栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/12/05 | 2,050 | 2,050 | 2,009 | 2,024 | -9 | -0.4% | 144,800 |
2019/12/04 | 1,992 | 2,036 | 1,970 | 2,033 | +23 | +1.1% | 160,900 |
2019/12/03 | 1,984 | 2,012 | 1,958 | 2,010 | +22 | +1.1% | 163,900 |
2019/12/02 | 1,996 | 2,001 | 1,972 | 1,988 | +14 | +0.7% | 121,700 |
2019/11/29 | 1,992 | 2,007 | 1,962 | 1,974 | +2 | +0.1% | 126,800 |
2019/11/28 | 1,967 | 1,974 | 1,925 | 1,972 | -21 | -1.1% | 199,900 |
2019/11/27 | 1,979 | 1,999 | 1,961 | 1,993 | +13 | +0.7% | 129,500 |
2019/11/26 | 1,998 | 2,016 | 1,976 | 1,980 | -12 | -0.6% | 287,800 |
2019/11/25 | 1,994 | 2,002 | 1,971 | 1,992 | +12 | +0.6% | 185,000 |
2019/11/22 | 1,954 | 1,993 | 1,946 | 1,980 | +34 | +1.7% | 223,200 |
2019/11/21 | 1,905 | 1,975 | 1,905 | 1,946 | +1 | +0.1% | 298,000 |
2019/11/20 | 1,904 | 1,945 | 1,898 | 1,945 | +40 | +2.1% | 209,700 |
2019/11/19 | 1,881 | 1,905 | 1,874 | 1,905 | +16 | +0.8% | 111,700 |
2019/11/18 | 1,894 | 1,907 | 1,872 | 1,889 | +9 | +0.5% | 112,300 |
2019/11/15 | 1,868 | 1,888 | 1,847 | 1,880 | +30 | +1.6% | 165,400 |
2019/11/14 | 1,850 | 1,861 | 1,822 | 1,850 | ±0 | ±0% | 161,700 |
2019/11/13 | 1,850 | 1,883 | 1,839 | 1,850 | +6 | +0.3% | 196,900 |
2019/11/12 | 1,858 | 1,860 | 1,824 | 1,844 | -30 | -1.6% | 164,800 |
2019/11/11 | 1,803 | 1,888 | 1,801 | 1,874 | +80 | +4.5% | 372,200 |
2019/11/08 | 1,810 | 1,814 | 1,780 | 1,794 | -5 | -0.3% | 135,300 |
2019/11/07 | 1,810 | 1,823 | 1,789 | 1,799 | +8 | +0.4% | 203,900 |
2019/11/06 | 1,810 | 1,813 | 1,778 | 1,791 | -18 | -1% | 112,900 |
2019/11/05 | 1,792 | 1,816 | 1,772 | 1,809 | +42 | +2.4% | 229,300 |
2019/11/01 | 1,740 | 1,768 | 1,730 | 1,767 | +10 | +0.6% | 141,500 |
2019/10/31 | 1,786 | 1,789 | 1,742 | 1,757 | -28 | -1.6% | 216,700 |
2019/10/30 | 1,772 | 1,791 | 1,748 | 1,785 | -10 | -0.6% | 272,500 |
2019/10/29 | 1,755 | 1,795 | 1,731 | 1,795 | +66 | +3.8% | 587,100 |
2019/10/28 | 1,805 | 1,829 | 1,695 | 1,729 | -155 | -8.2% | 1,192,500 |
2019/10/25 | 1,849 | 1,892 | 1,801 | 1,884 | +59 | +3.2% | 800,600 |
2019/10/24 | 1,792 | 1,858 | 1,739 | 1,825 | +226 | +14.1% | 1,449,000 |
2019/10/23 | 1,600 | 1,605 | 1,587 | 1,599 | +16 | +1% | 131,400 |
2019/10/21 | 1,590 | 1,606 | 1,581 | 1,583 | -7 | -0.4% | 120,100 |
2019/10/18 | 1,600 | 1,621 | 1,586 | 1,590 | -10 | -0.6% | 99,400 |
2019/10/17 | 1,626 | 1,626 | 1,589 | 1,600 | -17 | -1.1% | 147,900 |
2019/10/16 | 1,623 | 1,643 | 1,613 | 1,617 | +22 | +1.4% | 116,600 |
2019/10/15 | 1,596 | 1,607 | 1,587 | 1,595 | +32 | +2% | 96,000 |
2019/10/11 | 1,580 | 1,583 | 1,563 | 1,563 | -7 | -0.4% | 84,800 |
2019/10/10 | 1,581 | 1,581 | 1,535 | 1,570 | -11 | -0.7% | 109,500 |
2019/10/09 | 1,586 | 1,589 | 1,573 | 1,581 | -23 | -1.4% | 93,800 |
2019/10/08 | 1,589 | 1,607 | 1,584 | 1,604 | +19 | +1.2% | 77,600 |
2019/10/07 | 1,569 | 1,590 | 1,559 | 1,585 | +21 | +1.3% | 78,500 |
2019/10/04 | 1,561 | 1,568 | 1,542 | 1,564 | +4 | +0.3% | 97,200 |
2019/10/03 | 1,569 | 1,569 | 1,549 | 1,560 | -28 | -1.8% | 126,400 |
2019/10/02 | 1,588 | 1,601 | 1,584 | 1,588 | -14 | -0.9% | 140,200 |
2019/10/01 | 1,611 | 1,620 | 1,595 | 1,602 | -31 | -1.9% | 189,800 |
2019/09/30 | 1,614 | 1,640 | 1,610 | 1,633 | -9 | -0.5% | 128,700 |
2019/09/27 | 1,659 | 1,666 | 1,622 | 1,642 | -26 | -1.6% | 181,300 |
2019/09/26 | 1,698 | 1,708 | 1,657 | 1,668 | -16 | -1% | 183,600 |
2019/09/25 | 1,699 | 1,708 | 1,660 | 1,684 | -16 | -0.9% | 114,500 |
2019/09/24 | 1,713 | 1,742 | 1,686 | 1,700 | -13 | -0.8% | 164,800 |
1201~
1250
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 30.69倍 | 1.75倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム